Discover open access scientific publications

Search, annotate, share and cite publications

Publications by V. Pöschel

FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY

Hematological Oncology

English

Related publications

Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop

Hematological Oncology

English

Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis

Hematological Oncology

English

Male Gender Is an Independent Predictor for Worse Survival and Relapse in a Large, Consecutive Cohort of Elderly DLBCL Patients Treated With R‐ CHOP

British Journal of Haematology

Hematology

2019

English

Polarix: A Phase 3 Study of Polatuzumab Vedotin (Pola) Plus R-CHP Versus R-Chop in Patients (Pts) With Untreated DLBCL

Hematological Oncology

English

CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like

Hematological Oncology

English

Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis

BioMed Research International

English

Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated With Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

Biology of Blood and Marrow Transplantation

Transplantation

Hematology

2019

English

First-Line Treatment of Inhl or MCL Patients With Br or R-Chop/R-Cvp: Results of the Bright 5-Year Follow-Up Study

Hematological Oncology

English

Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop

Hematological Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by V. Pöschel

FIRST-LINE THERAPY OF ELDERLY PATIENTS WITH DLBCL-A COMPARISON OF STUDY PATIENTS TREATED WITH R-Chop ON THE RICOVER-60 TRIAL AND PATIENTS TREATED WITH R-Cyclophosphamide, EPIRUBICIN, VINDESINE, PREDNISONE (R-EpiVDSP) AT PEKING UNIVERSITY

Related publications

Elevated Expression of Lag3 Is Associated With Poor Outcome in Patients With DLBCL Treated With R-Chop

Negative Impact of Zoledronic Acid in R-Chop Treated DLBCL With Bone Metastasis

Male Gender Is an Independent Predictor for Worse Survival and Relapse in a Large, Consecutive Cohort of Elderly DLBCL Patients Treated With R‐ CHOP

Polarix: A Phase 3 Study of Polatuzumab Vedotin (Pola) Plus R-CHP Versus R-Chop in Patients (Pts) With Untreated DLBCL

CD30 Expression in Diffuse Large B-Cell Lymphoma Correlates With Non-GCB Subtype but Does Not Have Prognostic Impact in Patients Treated With First Line R-Chop/R-Chop-Like

Predictive Value of Interim PET/CT in DLBCL Treated With R-Chop: Meta-Analysis

Prediction of CAR T-Related Toxicities in R/R DLBCL Patients Treated With Axicabtagene Ciloleucel Using Point of Care Cytokine Measurements

First-Line Treatment of Inhl or MCL Patients With Br or R-Chop/R-Cvp: Results of the Bright 5-Year Follow-Up Study

Gene Mutations and Copy Number Alterations (Cna) Predict for Early Failure in Patients With Diffuse Large B-Cell Lymphoma (Dlbcl) Treated With R-Chop